Calamos Advisors
NVO icon

Calamos Advisors’s Novo Nordisk NVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.7M Sell
111,627
-377
-0.3% -$26K 0.03% 459
2025
Q1
$7.78M Sell
112,004
-34,862
-24% -$2.42M 0.03% 424
2024
Q4
$12.6M Sell
146,866
-73,753
-33% -$6.34M 0.05% 337
2024
Q3
$26.3M Sell
220,619
-83,724
-28% -$9.97M 0.11% 202
2024
Q2
$43.4M Sell
304,343
-3,998
-1% -$571K 0.19% 114
2024
Q1
$39.6M Sell
308,341
-15,413
-5% -$1.98M 0.19% 138
2023
Q4
$33.5M Sell
323,754
-8,584
-3% -$888K 0.16% 166
2023
Q3
$30.2M Buy
332,338
+165,928
+100% +$15.1M 0.16% 167
2023
Q2
$26.9M Sell
166,410
-29,780
-15% -$4.82M 0.13% 191
2023
Q1
$31.2M Sell
196,190
-33,931
-15% -$5.4M 0.15% 166
2022
Q4
$31.1M Sell
230,121
-30,066
-12% -$4.07M 0.15% 175
2022
Q3
$25.9M Sell
260,187
-8,306
-3% -$828K 0.12% 199
2022
Q2
$29.9M Buy
268,493
+41,627
+18% +$4.64M 0.13% 183
2022
Q1
$25.2M Sell
226,866
-1,384
-0.6% -$154K 0.09% 233
2021
Q4
$25.6M Buy
228,250
+10,536
+5% +$1.18M 0.1% 218
2021
Q3
$20.9M Buy
217,714
+2,547
+1% +$245K 0.09% 230
2021
Q2
$18M Buy
215,167
+41,686
+24% +$3.49M 0.08% 255
2021
Q1
$11.7M Sell
173,481
-91,699
-35% -$6.18M 0.06% 286
2020
Q4
$18.5M Sell
265,180
-111,287
-30% -$7.77M 0.11% 209
2020
Q3
$26.1M Buy
376,467
+29,804
+9% +$2.07M 0.17% 147
2020
Q2
$22.7M Buy
346,663
+96,159
+38% +$6.3M 0.16% 161
2020
Q1
$15.1M Buy
250,504
+223,404
+824% +$13.4M 0.12% 210
2019
Q4
$1.57M Buy
27,100
+6,700
+33% +$388K 0.01% 599
2019
Q3
$1.06M Hold
20,400
0.01% 598
2019
Q2
$1.04M Hold
20,400
0.01% 608
2019
Q1
$1.07M Buy
+20,400
New +$1.07M 0.01% 516
2013
Q3
Sell
-47,750
Closed -$7.4M 600
2013
Q2
$7.4M Buy
+47,750
New +$7.4M 0.05% 238